Company intelligence / Profile preview

Bendalis

Oberhaching, Bavaria, Germany

Ownership: Private
Development stage: Other

Overview

Bendalis is a commercial-stage specialty pharmaceutical company that develops and markets generic and niche proprietary oncology and supportive care small-molecule products, primarily for hematology/oncology indications, in Germany and international markets.[1][5][2][3]

Therapeutic areas: OncologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Partnerships

Inceptua Group (exclusive global clinical trial supply agreement for oncology generics)[2][3]EUSA Pharma (distribution of Caphosol for oral mucositis)[1]Riemser Arzneimittel (distribution of ALOXI for chemotherapy-induced nausea and vomiting)[1]AgainLife (distribution of supportive care medical devices/products)[1][6]Inresa Arzneimittel (distribution partnership for Somatostatin Lyomark 3 mg)[6]

Beyond the preview

Go deeper on Bendalis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bendalis.

Explore the full profile